Cargando…

Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection

Adjuvant S-1 monotherapy is the standard of care for stage II gastric cancer (GC) after curative resection in Japan, but its efficacy for microsatellite instability–high (MSI-H) tumors has remained unknown. Among a multi-institutional cohort of patients with stage II GC who underwent R0 resection fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Chihiro, Kawakami, Hisato, Tanaka, Ryo, Satake, Hironaga, Inoue, Kentaro, Kimura, Yutaka, Fujita, Junya, Kawabata, Ryohei, Chiba, Yasutaka, Satoh, Taroh, Nakagawa, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319738/ https://www.ncbi.nlm.nih.gov/pubmed/37402831 http://dx.doi.org/10.1038/s41598-023-37870-y

Ejemplares similares

Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer
por: Muro, Kei, et al.
Publicado: (2023)

The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
por: Inagaki, Chiaki, et al.
Publicado: (2023)

Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study
por: Sakai, Daisuke, et al.
Publicado: (2022)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
por: Kobayashi, Toshinori, et al.
Publicado: (2023)

Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity
por: Ninomiya, H, et al.
Publicado: (2006)

Editorial: Microsatellite and microsatellite instability
por: How-Kit, Alexandre, et al.
Publicado: (2023)

Contribution of MMP14-expressing cancer-associated fibroblasts in the tumor immune microenvironment to progression of colorectal cancer
por: Makutani, Yusuke, et al.
Publicado: (2022)

Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors
por: Li, Jian, et al.
Publicado: (2021)

Comprehensive analysis of indels in whole-genome microsatellite regions and microsatellite instability across 21 cancer types
por: Fujimoto, Akihiro, et al.
Publicado: (2020)

Phase II Trial of 5‐Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer
por: Ueda, Hiroto, et al.
Publicado: (2018)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
por: Mukai, Shohei, et al.
Publicado: (2021)

Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer
por: Yonesaka, Kimio, et al.
Publicado: (2015)

A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing
por: Sakai, Kazuko, et al.
Publicado: (2019)

Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S − 1 therapy
por: Yamaguchi, Toshifumi, et al.
Publicado: (2022)

Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)
por: Matsuyama, Jin, et al.
Publicado: (2022)

A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302)
por: Tamura, Shigeyuki, et al.
Publicado: (2020)

Microsatellite instability in ovarian neoplasms.
por: King, B. L., et al.
Publicado: (1995)

Microsatellite instability in colorectal cancer
por: Horvat, Matej, et al.
Publicado: (2011)

Microsatellite instability in colorectal cancer
por: Nojadeh, Jafar Nouri, et al.
Publicado: (2018)

Microsatellite instability in colorectal cancer
por: Gian, Luigi de’Angelis, et al.
Publicado: (2018)

Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
por: Ogata, Takatsugu, et al.
Publicado: (2020)

The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results
por: Terazawa, Tetsuji, et al.
Publicado: (2022)

Characterizing Microsatellite Instability and Chromosome Instability in Interval Colorectal Cancers
por: Cisyk, Amy L., et al.
Publicado: (2018)

Microsatellite instability in human prostate cancer.
por: Watanabe, M., et al.
Publicado: (1995)

No evidence of microsatellite instability in bone tumours.
por: Tarkkanen, M., et al.
Publicado: (1996)

Infrequent microsatellite instability in oesophageal cancers.
por: Muzeau, F., et al.
Publicado: (1997)

Microsatellite Instability in Sarcoma: Fact or Fiction?
por: Monument, Michael J., et al.
Publicado: (2012)

Lynch Syndrome (HNPCC) and Microsatellite Instability
por: Umar, Asad
Publicado: (2004)

Endometrial cancer and microsatellite instability status
por: Kanopiene, Daiva, et al.
Publicado: (2014)

Hypermutation and microsatellite instability in gastrointestinal cancers
por: Yuza, Kizuki, et al.
Publicado: (2017)

Microsatellite Instability in Medullary Carcinoma of the Colon
por: Martinotti, Mario, et al.
Publicado: (2017)

Microsatellite instability and chemosensitivity in solid tumours
por: Cherri, Sara, et al.
Publicado: (2022)

Clinical and immune profiling for cancer of unknown primary site
por: Haratani, Koji, et al.
Publicado: (2019)

Medullary colonic carcinoma with microsatellite instability has lower survival compared with conventional colonic adenocarcinoma with microsatellite instability
por: Gómez-Álvarez, Miguel A., et al.
Publicado: (2016)

Clinical predominance of whole‐exome sequencing to evaluate microsatellite instability status
por: Takamatsu, Reika, et al.
Publicado: (2023)

Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
por: Nakamura, Yoshiaki, et al.
Publicado: (2022)

Microsatellite Instability in Lung Cancer Patients 40 Years of Age or Younger
por: Sekine, Ikuo, et al.
Publicado: (1997)

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer
por: Trullas, A., et al.
Publicado: (2021)

Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment
por: Aoyama, Yumiko, et al.
Publicado: (2012)

Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
por: Yamashita, Hitomi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9rj57bq02u0re1547pbt6rl7ic